DarioHealth Corp. Annual Report - How They Did This Year

What We've Learned So Far (from the latest filing info):

We don't have their full financial results yet. But we can see key details about their business and finances.

• Business Growth & Assets: DarioHealth made a significant move by acquiring Twill Inc. (formerly Happify Health) in September 2022 for about $200 million, paid with company shares. This acquisition greatly expanded DarioHealth's digital mental health services, adding many users and specialized AI technology. The latest annual report highlights valuable assets, including technology and customer relationships, primarily from Twill. These assets are crucial for DarioHealth's comprehensive digital health platform and were mentioned in February 2024 as reflecting their updated value and integration, showing their impact on the company's financial health and future growth for 2023.

• How They Reach Customers: DarioHealth's many ways of reaching customers are key to its growth. With its B2B2C (Business-to-Business-to-Consumer) model, the company partners with employers, health plans, and healthcare providers. They integrate digital health solutions for chronic conditions like diabetes, high blood pressure, weight, and mental health directly into benefit plans. This lets DarioHealth reach many potential users easily. Direct sales to consumers, though they bring in less money, offer market insights and build their brand. "Strategic Partnerships" go beyond B2B2C, often involving collaborations with drug companies for digital therapies, device makers for combined solutions, or tech platforms to embed their services. This helps them reach more markets and improve their products.

• Funding Their Operations: DarioHealth's way of funding shows many rounds of raising money to pay for its growth and purchases. The different "Series" of preferred stock (C, D, D1, D2, D3) mean the company raised money from big investors through several private deals over time. These preferred shares usually come with special rights, like getting paid first if the company closes, protection against dilution, and the ability to convert to common stock, which can affect regular shareholders. "Warrants" give holders the right to buy common stock at a set price. Companies often issue them with preferred stock or debt to make the deal more attractive to investors. If exercised, they mean more shares issued, reducing your ownership percentage. Also, "Senior Secured Credit Facilities" and "Loans" usually pay for daily operations, general company needs, or specific projects, like buying Twill. These loans are backed by the company's assets, come with interest payments, and often have rules DarioHealth must follow. They offer a lot of cash but also add financial risk.

Potential Things to Keep an Eye On:

• Customer Concentration: The report flags "Customer Concentration Risk." This means a lot of their sales or money due to them comes from just one or a few major customers. This is common for companies with a few big contracts, especially in B2B2C healthcare where deals with large employers or health plans can be substantial. If a key customer ends their contract, cuts services, or faces money problems, DarioHealth could see a significant and quick drop in sales, available cash, and profit. This highlights the importance of having many different customers and maintaining strong ties with big clients.

We're still waiting for the real financial results. This includes their sales, profit, or how costs changed from last year. Once we have those, we can give you a clearer picture of their true performance. Then we'll know what that means for your investment!